Advertisement

Topics

Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress

16:05 EST 8 Nov 2017 | BioMedReports - Blog

U.S. product revenue was $70.9 millionin the third quarter of 2017, compared with $70.0 millionin the third quarter of 2016. U.S. invasive breast

Read more...

Original Article: Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress

NEXT ARTICLE

More From BioPortfolio on "Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...